Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Polaryx Therapeutics, Inc. (PLYX) had Non-Operating Income/Expense of $-0.59M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-2.54M |
|
-- |
|
-- |
|
$1.96M |
|
$-1.96M |
|
|
Non-Operating Income/Expense |
$-0.59M |
$-2.54M |
|
$-2.54M |
|
$-2.54M |
|
$-2.54M |
|
$-2.54M |
|
$-2.54M |
|
$-1.96M |
|
$-1.96M |
|
47.22M |
|
47.22M |
|
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$3.50M |
|
-- |
|
-- |
|
$3.50M |
|
$1.01M |
|
-- |
|
-- |
|
$1.01M |
|
$2.49M |
|
$2.49M |
|
$2.49M |
|
47.34M |
|
| Cash Flow Statement Financials | |
$-2.06M |
|
-- |
|
-- |
|
$5.14M |
|
$3.08M |
|
$-2.06M |
|
$0.47M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.45 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.06M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-102.25% |
|
-102.25% |
|
-72.64% |
|
-102.25% |
|
$0.05 |
|
$-0.04 |
|
$-0.04 |
|